The phakomatoses

Clinics in Dermatology

Volumn 23, Issue 1, 2005, Pages 78-84

  Korf, Bruce R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETICS; HUMAN; INHERITANCE; NEURILEMOMA; NEUROFIBROMATOSIS; PATHOGENESIS; PHAKOMATOSIS; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 13544258632     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.09.007     Document Type: Review

References (85)

1. A.G. Knudson Mutation and cancer: statistical study of retinoblastoma Proc. Natl. Acad. Sci. U. S. A. 68 1971 820 823
2. L. Rubenstein The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis: a neuropathological study of 22 cases Ann. N. Y. Acad. Sci. 486 1986 14 29
3. S.M. Huson, P.S. Harper, and D.A.S. Compston Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales Brain 111 1988 1355 1381
4. B.R. Korf Plexiform neurofibromas Am. J. Med. Genet. 89 1999 31 37
5. D.G. Evans, M.E. Baser, and J. McGaughran Malignant peripheral nerve sheath tumours in neurofibromatosis 1 J. Med. Genet. 39 2002 311 314
6. B.R. Korf Diagnostic outcome in children with multiple café au lait spots Pediatrics 90 1992 924 927
7. M.-L.E. Lubs, M.S. Bauer, and M.E. Formas Lisch nodules in neurofibromatosis type 1 N. Engl. J. Med. 324 1991 1264 1266
8. R. Listernick, D.N. Louis, and R.J. Packer Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force Ann. Neurol. 41 1997 143 149
9. A.H. Crawford, and E.K. Schorry Neurofibromatosis in children: the role of the orthopaedist J. Am. Acad. Orthop. Surg. 7 1999 217 230
10. K.N. North, V. Riccardi, and C. Samango-Sprouse Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force Neurology 48 1997 1121 1127
11. S.A. Rasmussen, Q. Yang, and J. Friedman Mortality in neurofibromatosis 1: an analysis using U.S. death certificates Am. J. Hum. Genet. 68 2001 1110 1118
12. D.H. Gutmann, and F.S. Collins The neurofibromatosis type 1 gene and its protein product, neurofibromin Neuron 10 1993 335 343
13. G. Xu, P. O'Connell, and D. Viskochil The neurofibromatosis type 1 gene encodes a protein related to GAP Cell 62 1990 599 608
14. F. McCormick The superfamily of Ras-related GTPases Jpn. J. Cancer Res. 88 1997 COV1 COV2
15. M.M. Feldkamp, D.H. Gutmann, and A. Guha Neurofibromatosis type 1: piecing the puzzle together Can. J. Neurol. Sci. 25 1998 181 191
16. K. Cichowski, and T. Jacks NF1 tumor suppressor gene function: narrowing the GAP Cell 104 2001 593 604
17. E. Serra, T. Rosenbaum, and U. Winner Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations Hum. Mol. Genet. 9 2000 3055 3064
18. L.S. Sherman, R. Atit, and T. Rosenbaum Single cell ras-GTP analysis reveals altered ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts J. Biol. Chem. 275 2000 30740 30745
19. L.M. Messiaen, T. Callens, and G. Mortier Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects Hum. Mutat. 15 2000 541 555
20. L.M. Kayes, W. Burke, and V.M. Riccardi Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients Am. J. Hum. Genet. 54 1994 424 436
21. R. Listernick, A.J. Mancini, and J. Charrow Segmental neurofibromatosis in childhood Am. J. Med. Genet. 121A 2003 132 135
22. S. Tinschert, I. Naumann, and E. Stegmann Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene Eur. J. Hum. Genet. 8 2000 455 459
23. C. Lázaro, A. Ravella, and A. Gaona Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father N. Engl. J. Med. 331 1994 1403 1407
24. D.G. Evans, M. Sainio, and M.E. Baser Neurofibromatosis type 2 J. Med. Genet. 37 2000 897 904
25. M.E. Baser, R.D.G. Evans, and D.H. Gutmann Neurofibromatosis 2 Curr. Opin. Neurol. 16 2003 27 33
26. D.G. Evans, R. Lye, and W. Neary Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma J. Neurol. Neurosurg. Psychiatry 66 1999 764 767
27. E.A. Bouzas, D.M. Parry, and R. Eldridge Visual impairment in patients with neurofibromatosis 2 Neurology 43 1993 622 623
28. J.F. Gusella, V. Ramesh, and M. MacCollin Merlin: the neurofibromatosis 2 tumor suppressor Biochim. Biophys. Acta 1423 1999 M29 M36
29. J.A. Trofatter, M.M. MacCollin, and J.L. Rutter A novel moeisin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 72 1993 791 800
30. G.A. Rouleau, P. Merel, and M. Lutchman Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Nature 363 1993 515 521
31. J.J. Meng, D.J. Lowrie, and H. Sun Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin J. Neurosci. Res. 62 2000 491 502
32. B.R. Seizinger, G. Rouleau, and L.J. Ozelius Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis Science 236 1987 317 319
33. M.H. Ruttledge, A.A. Andermann, and C.M. Phelan Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease Am. J. Hum. Genet. 59 1996 331 342
34. D.M. Parry, M.M. MacCollin, and M.I. Kaiser-Kupfer Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities Am. J. Hum. Genet. 59 1996 529 539
35. M.E. Baser, L. Kuramoto, and H. Joe Genotype-phenotype correlations for cataracts in neurofibromatosis 2 J. Med. Genet. 40 2003 758 760
36. D.G. Evans, A.J. Wallace, and C.L. Wu Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis Am. J. Hum. Genet. 63 1998 727 736
37. L. Kluwe, and V.F. Mautner Mosaicism in sporadic neurofibromatosis 2 patients Hum. Mol. Genet. 7 1998 2051 2055
38. M.E. Baser, A.J. Wallace, and T. Strachan Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2 J. Med. Genet. 37 2000 542 543
39. M. MacCollin, W. Woodfin, and D. Kronn Schwannomatosis: a clinical and pathologic study Neurology 46 1996 1072 1079
40. S.M. Purcell, and S.L. Dixon Schwannomatosis: an unusual variant of neurofibromatosis or a distinct clinical entity Arch. Dermatol. 125 1989 390 393
41. P. Wolkenstein, H. Benchikhi, and J. Zeller Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2 Dermatology 195 1997 228 231
42. M. MacCollin, C. Willett, and B. Heinrich Familial schwannomatosis: exclusion of the NF2 locus as the germline event Neurology 60 2003 1968 1974
43. D.L. Kaufman, B.S. Heinrich, and C. Willett Somatic instability of the NF2 gene in schwannomatosis Arch. Neurol. 60 2003 1317 1320
44. D.N. Franz Diagnosis and management of tuberous sclerosis complex Semin. Pediatr. Neurol. 5 1998 253 268
45. D.W. Webb, and J.P. Osborne Tuberous sclerosis Arch. Dis. Child. 72 1995 471 474
46. D.W. Webb, A.E. Fryer, and J.P. Osborne Morbidity associated with tuberous sclerosis: a population study Dev. Med. Child Neurol. 38 1996 146 155
47. P.B. Crino, J.Q. Trojanowski, and M.A. Dichter Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology Proc. Natl. Acad. Sci. U. S. A. 93 1996 14152 14157
48. S.K. Kim, K.C. Wang, and B.K. Cho Biological behavior and tumorigenesis of subependymal giant cell astrocytomas J. Neurooncol. 52 2001 217 225
49. D.W. Webb, A. Clarke, and A. Fryer The cutaneous features of tuberous sclerosis: a population study Br. J. Dermatol. 135 1996 1 5
50. S.A. Rowley, F.J. O'Callaghan, and J.P. Osborne Ophthalmic manifestations of tuberous sclerosis: a population based study Br. J. Ophthalmol. 85 2001 420 423
51. F.J. DiMario, D. Diana, and H. Leopold Evolution of cardiac rhabdomyoma in tuberous sclerosis complex Clin. Pediatr. (Phila.) 35 1996 615 619
52. J.A. Cook, K. Oliver, and R.F. Mueller A cross sectional study of renal involvement in tuberous sclerosis J. Med. Genet. 33 1996 480 484
53. P.T. Brook-Carter, B. Peral, and C.J. Ward Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-a contiguous gene syndrome Nat. Genet. 8 1994 328 332
54. P.C. Harris The TSC2/PKD1 contiguous gene syndrome Contrib. Nephrol. 122 1997 76 82
55. G.D. Strizheva, T. Carsillo, and W.D. Kruger The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis Am. J. Respir. Crit. Care Med. 163 2001 253 258
56. M.H. Hyman, and V.H. Whittemore National Institutes of Health consensus conference: tuberous sclerosis complex Arch. Neurol. 57 2000 662 665
57. M. Van Slegtenhorst, B. Janssen, and M. Nellist Cosmid contigs from the tuberous sclerosis candidate region on chromosome 9q34 Eur. J. Hum. Genet. 3 1995 78 86
58. The European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterisation of the tuberous sclerosis gene on chromosome 16 Cell 75 1993 1 11
59. V.P. Krymskaya Tumour suppressors hamartin and tuberin: intracellular signalling Cell. Signal. 15 2003 729 739
60. E.P. Henske, H.P. Neumann, and B.W. Scheithauer Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas Genes Chromosomes Cancer 13 1995 295 298
61. E.P. Henske, B.W. Scheithauer, and M.P. Short Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions Am. J. Hum. Genet. 59 1996 400 406
62. E.P. Henske, L.L. Wessner, and J. Golden Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors Am. J. Pathol. 151 1997 1639 1647
63. O. Hino, S. Majima, and T. Kobayashi Multistep renal carcinogenesis as gene expression disease in tumor suppressor TSC2 gene mutant model-genotype, phenotype and environment Mutat. Res. 477 2001 155 164
64. G. Rennebeck, E.V. Kleymenova, and R. Anderson Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development Proc. Natl. Acad. Sci. U. S. A. 95 1998 15629 15634
65. K. Suzuki, T. Ogura, and T. Yokose Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia Int. J. Cancer 79 1998 384 389
66. S.L. Dabora, S. Jozwiak, and D.N. Franz Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs Am. J. Hum. Genet. 68 2001 64 80
67. J.B. Ali, T. Sepp, and S. Ward Mutations in the TSC1 gene account for a minority of patients with tuberous sclerosis J. Med. Genet. 35 1998 969 972
68. R.L. Beauchamp, A. Banwell, and P. McNamara Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis Hum. Mutat. 12 1998 408 416
69. A.C. Jones, M.M. Shyamsundar, and M.W. Thomas Comprehensive mutation analysis of TSC1 and TSC2- and phenotypic correlations in 150 families with tuberous sclerosis Am. J. Hum. Genet. 64 1999 1305 1315
70. Y. Niida, N. Lawrence-Smith, and A. Banwell Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis Hum. Mutat. 14 1999 412 422
71. Y. Niida, A.O. Stemmer-Rachamimov, and M. Logrip Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions Am. J. Hum. Genet. 69 2001 493 503
72. S. Verhoef, L. Bakker, and A.M. Tempelaars High rate of mosaicism in tuberous sclerosis complex Am. J. Hum. Genet. 64 1999 1632 1637
73. J.E. Conway, D. Chou, and R.E. Clatterbuck Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease Neurosurgery 48 2001 55 62
74. T.J. Manski, D.K. Heffner, and G.M. Glenn Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease JAMA 277 1997 1461 1466
75. D. Chauveau, C. Duvic, and Y. Chretien Renal involvement in von Hippel-Lindau disease Kidney Int. 50 1996 944 951
76. F. Chen, T. Kishida, and M. Yao Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype Hum. Mutat. 5 1995 66 75
77. C.A. Friedrich Genotype-phenotype correlation in von Hippel-Lindau syndrome Hum. Mol. Genet. 10 2001 763 767
78. F.J. Hes, J.W. Hoppener, and C.J. Lips Clinical review 155: pheochromocytoma in von Hippel-Lindau disease J. Clin. Endocrinol. Metab. 88 2003 969 974
79. R.R. Lonser, G.M. Glenn, and M. Walther von Hippel-Lindau disease Lancet 361 2003 2059 2067
80. F. Latif, K. Tory, and J. Gnarra Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1993 1317 1320
81. W.G. Kaelin Jr. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing J. Am. Soc. Nephrol. 14 2003 2703 2711
82. E.R. Maher, A.R. Webster, and F.M. Richards Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations J. Med. Genet. 33 1996 328 332
83. B. Zbar, T. Kishida, and F. Chen Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan Hum. Mutat. 8 1996 348 357
84. S.D. Pack, B. Zbar, and E. Pak Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization Cancer Res. 59 1999 5560 5564
85. A. Murgia, M. Martella, and C. Vinanzi Somatic mosaicism in von Hippel-Lindau disease Hum. Mutat. 15 2000 114